| Literature DB >> 33976843 |
Samuel J Eliades1, Joseph C Brown1,2, Timothy J Colston3, Robert N Fisher4, Jone B Niukula5, Kim Gray6, Jhabar Vadada5, Sia Rasalato7, Cameron D Siler1.
Abstract
Animals often exhibit distinct microbial communities when maintained in captivity as compared to when in the wild. Such differentiation may be significant in headstart and reintroduction programs where individuals spend some time in captivity before release into native habitats. Using 16S rRNA gene sequencing, we (i) assessed differences in gut microbial communities between captive and wild Fijian crested iguanas (Brachylophus vitiensis) and (ii) resampled gut microbiota in captive iguanas released onto a native island to monitor microbiome restructuring in the wild. We used both cloacal swabs and fecal samples to further increase our understanding of gut microbial ecology in this IUCN Critically Endangered species. We found significant differentiation in gut microbial community composition and structure between captive and wild iguanas in both sampling schemes. Approximately two months postrelease, microbial communities in cloacal samples from formerly captive iguanas closely resembled wild counterparts. Interestingly, microbial communities in fecal samples from these individuals remained significantly distinct from wild conspecifics. Our results indicate that captive upbringings can lead to differences in microbial assemblages in headstart iguanas as compared to wild individuals even after host reintroduction into native conditions. This investigation highlights the necessity of continuous monitoring of reintroduced animals in the wild to ensure successful acclimatization and release.Entities:
Keywords: conservation; headstart; husbandry; microbial restructuring; reptiles; wildlife management
Year: 2021 PMID: 33976843 PMCID: PMC8093715 DOI: 10.1002/ece3.7373
Source DB: PubMed Journal: Ecol Evol ISSN: 2045-7758 Impact factor: 2.912
FIGURE 1Adult Fijian crested iguana (B. vitiensis) perched in native habitat on Monuriki Island (Photograph by J.C.B.)
FIGURE 2Principal coordinates analysis plots of initial (2017) (a) cloacal swabs and (b) fecal samples across four Fijian crested iguana treatment groups. Treatment groups include wild‐caught founders (WCF) in captivity and captive‐born headstart individuals (CB2017) in captivity at Kula Eco Park on Viti Levu, Fiji, as well as captive‐born individuals released onto Monuriki Island in 2015 (CB2015) and fully wild individuals on Monuriki Island (Wild). The number of individual samples per treatment group is indicated in parentheses
FIGURE 3Alpha‐diversity metrics of initial (2017) fecal samples across four treatment groups. Treatments included wild‐caught founder (WCF) iguanas in captivity, captive‐born headstart individuals (CB2017) in captivity, captive‐born individuals released onto Monuriki in 2015 (CB2015), and fully wild individuals on Monuriki Island (Wild). Paired symbols denote significantly distinct treatment groups
FIGURE 4Principal coordinates analysis of reintroduced and initial (2017) (a) cloacal swabs and (b) fecal samples across three Fijian crested iguana treatment groups. Captive prerelease samples include wild‐caught founders (WCF) in captivity and captive‐born headstart individuals (CB2017) in captivity at Kula Eco Park collected February 2017. Noncaptive individuals consist of captive‐born individuals released onto Monuriki Island in 2015 (CB2015) and fully wild individuals on Monuriki Island (Wild). Postrelease treatments include formerly captive WCF and CB2017 individuals sampled in late April 2017, 2 months after release onto Monuriki Island
FIGURE 5Alpha‐diversity metrics of fecal samples from reintroduced Fijian crested iguana hosts compared against initial samples. Captive prerelease samples include wild‐caught founders (WCF) in captivity and captive‐born headstart individuals (CB2017) in captivity at Kula Eco Park. Noncaptive individuals consist of captive‐born individuals released onto Monuriki Island in 2015 (CB2015) and fully wild individuals on Monuriki Island (Wild). Initial sample collection occurred in February 2017. Postrelease treatments include formerly captive WCF and CB2017 individuals sampled 2 months after release onto Monuriki Island in April 2017. Paired symbols denote significantly distinct treatment groups